Pathologic classification of prostate carcinoma

A proposed pathologic (pTNM) classification system for prostate carcinoma was analyzed for its impact on survival outcome in the prostate specific antigen (PSA) era. The impact of margin status on the survival outcome of patients with otherwise organ‐confined disease (i.e., without extraprostatic extension or seminal vesicle involvement) was assessed.

[1]  D. Wood,et al.  Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer , 1995 .

[2]  H. Neuwirth,et al.  Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy. , 1995, The Journal of urology.

[3]  T. Wheeler,et al.  Workgroup 2: Staging and reporting of prostate cancer‐‐Sampling of the radical prostatectomy specimen , 1996, Cancer.

[4]  M. Kattan,et al.  Prognostic significance of positive surgical margins in radical prostatectomy specimens. , 1995, The Journal of urology.

[5]  J. Montie.  Staging of prostate cancer. Current TNM classification and future prospects for prognostic factors , 1995 .

[6]  D. Grignon,et al.  Pathologic staging of prostate carcinoma: What are the issues? , 1996, Cancer.

[7]  J. Montie.  Staging of prostate cancer , 1994, Cancer.

[8]  D. Paulson.  Impact of radical prostatectomy in the management of clinically localized disease. , 1994, The Journal of urology.

[9]  E. Bergstralh,et al.  Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis. , 1996, The Journal of urology.

[10]  W. Whitmore.  The natural history of prostatic cancer , 1973, Progress in clinical and biological research.

[11]  W. Whitmore.  Proceedings: The natural history of prostatic cancer. , 1973, Cancer.

[12]  W. Catalona,et al.  Staging errors in clinically localized prostatic cancer. , 1982, The Journal of urology.

[13]  T. Stamey,et al.  Positive surgical margins at radical prostatectomy: importance of the apical dissection. , 1990, The Journal of urology.

[14]  A W Partin,et al.  Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. , 1993, The Journal of urology.

[15]  T. Therneau,et al.  Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy. , 1989, The Journal of urology.

[16]  R. B. Smith,et al.  Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. , 1992, The Journal of urology.

[17]  A. D'Amico,et al.  A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.

[18]  J. Oesterling,et al.  Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. , 1994, The Journal of urology.

[19]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[20]  P. Walsh,et al.  Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate. , 1989, The Journal of urology.

[21]  Galina Pizov,et al.  Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.